Structure and function of anticoagulation clinics in the United States: an AC forum membership survey

J Thromb Thrombolysis. 2018 Jul;46(1):7-11. doi: 10.1007/s11239-018-1652-z.

Abstract

Many anticoagulation clinics have adapted their services to provide care for patients taking direct oral anticoagulants (DOAC) in addition to traditional warfarin management. Anticoagulation clinic scope of service and operations in this transitional environment have not been well described in the literature. A survey was conducted of United States-based Anticoagulation Forum members to inquire about anticoagulation clinic structure, function, and services provided. Survey responses are reported using summary or non-parametric statistics, when appropriate. Unique clinic survey responses were received from 159 anticoagulation clinics. Clinic structure and staffing are highly variable, with approximately half of clinics (52%) providing DOAC-focused care in addition to traditional warfarin-focused care. Of those clinics managing DOAC patients, this accounts for only 10% of their clinic volume. These clinics commonly have a DOAC follow up protocol (75%). Clinics assign a median of 190.5 (interquartile range 50-300) patients per staff full-time-equivalent, with more patients assigned in phone-based care clinics than in face-to-face based care clinics. Most clinics (68.5%) report receiving reimbursement, which occur either through a combination of patient and insurance provider billing (78.2%), insurance reimbursement only (19.5%) or patient reimbursement only (2.3%). There is wide heterogeneity in anticoagulation clinic structure, function, and services provided. Half of all survey-responding anticoagulation clinics provide care for DOAC-treated patients. Understanding how changes in healthcare policy and reimbursement have impacted these clinics remains to be explored.

MeSH terms

  • Administration, Oral
  • Ambulatory Care Facilities / economics
  • Ambulatory Care Facilities / organization & administration*
  • Anticoagulants / administration & dosage
  • Anticoagulants / therapeutic use*
  • Humans
  • Reimbursement Mechanisms / statistics & numerical data
  • Surveys and Questionnaires
  • United States
  • Warfarin / therapeutic use

Substances

  • Anticoagulants
  • Warfarin